Lantheus Holdings Cash on Hand 2013-2019 | LNTH
Lantheus Holdings cash on hand from 2013 to 2019. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| Lantheus Holdings Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2018 | $113 |
| 2017 | $76 |
| 2016 | $51 |
| 2015 | $29 |
| 2014 | $20 |
| 2013 | $19 |
| 2012 | $0 |
| Lantheus Holdings Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| Q1 2019 | $112 |
| Q4 2018 | $113 |
| Q3 2018 | $105 |
| Q2 2018 | $86 |
| Q1 2018 | $74 |
| Q4 2017 | $76 |
| Q3 2017 | $68 |
| Q2 2017 | $57 |
| Q1 2017 | $41 |
| Q4 2016 | $51 |
| Q3 2016 | $53 |
| Q2 2016 | $55 |
| Q1 2016 | $39 |
| Q4 2015 | $29 |
| Q3 2015 | $22 |
| Q2 2015 | $22 |
| Q1 2015 | $0 |
| Q4 2014 | $0 |
| Q3 2014 | $0 |
| Q2 2014 | $0 |
| Q4 2013 | $19 |
| Q4 2012 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.960B | $0.343B |
| Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $135.807B | 26.36 |
| Medtronic (MDT) | Ireland | $124.767B | 17.82 |
| Stryker (SYK) | United States | $68.939B | 24.60 |
| Boston Scientific (BSX) | United States | $53.498B | 25.65 |
| Baxter (BAX) | United States | $38.314B | 24.15 |
| Zimmer Biomet Holdings (ZBH) | United States | $23.454B | 15.07 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $18.518B | 0.00 |
| ResMed (RMD) | United States | $16.331B | 31.20 |
| Canopy Growth (CGC) | Canada | $15.286B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.742B | 46.35 |
| Aurora Cannabis (ACB) | Canada | $8.427B | 83.10 |
| Hill-Rom Holdings (HRC) | United States | $6.498B | 19.70 |
| Insulet (PODD) | United States | $6.479B | 472.04 |
| Perrigo (PRGO) | Ireland | $6.439B | 10.89 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $5.538B | 0.00 |
| Haemonetics (HAE) | United States | $5.172B | 42.26 |
| ICU Medical (ICUI) | United States | $4.652B | 27.76 |
| Hutchison China MediTech (HCM) | China | $3.574B | 0.00 |
| NuVasive (NUVA) | United States | $3.193B | 26.07 |
| Neogen (NEOG) | United States | $2.975B | 48.36 |
| Agios Pharmaceuticals (AGIO) | United States | $2.838B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.257B | 48.10 |
| Quidel (QDEL) | United States | $2.184B | 22.66 |
| Aphria (APHA) | $1.843B | 0.00 | |
| Cardiovascular Systems (CSII) | United States | $1.376B | 790.40 |
| Phibro Animal Health (PAHC) | United States | $1.203B | 18.02 |
| AtriCure (ATRC) | United States | $1.140B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.042B | 22.11 |
| NanoString Technologies (NSTG) | United States | $0.973B | 0.00 |
| MacroGenics (MGNX) | United States | $0.920B | 0.00 |
| Omeros (OMER) | United States | $0.876B | 0.00 |
| PetIQ (PETQ) | United States | $0.779B | 18.92 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.756B | 21.21 |
| Cerus (CERS) | United States | $0.715B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.633B | 0.00 |
| Surmodics (SRDX) | United States | $0.572B | 83.22 |
| LeMaitre Vascular (LMAT) | United States | $0.524B | 25.35 |
| OraSure Technologies (OSUR) | United States | $0.509B | 23.46 |
| Quanterix (QTRX) | United States | $0.505B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $0.477B | 14.57 |
| Evolus (EOLS) | United States | $0.440B | 0.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.336B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.330B | 103.12 |
| Utah Medical Products (UTMD) | United States | $0.302B | 20.93 |
| Vapotherm (VAPO) | United States | $0.284B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.272B | 0.00 |
| Zynex (ZYXI) | United States | $0.230B | 23.80 |
| Owens & Minor (OMI) | United States | $0.219B | 4.64 |
| Cytosorbents (CTSO) | United States | $0.213B | 0.00 |
| Bovie Medical (APYX) | United States | $0.198B | 0.00 |
| Chimerix (CMRX) | United States | $0.184B | 0.00 |
| Fonar (FONR) | United States | $0.130B | 6.83 |
| Chembio Diagnostics (CEMI) | United States | $0.120B | 0.00 |
| BRAINSWAY LTD (BWAY) | Israel | $0.118B | 0.00 |
| Female Health (VERU) | United States | $0.112B | 0.00 |
| Surface Oncology (SURF) | United States | $0.107B | 0.00 |
| United-Guardian (UG) | United States | $0.091B | 20.10 |
| Neurotrope (NTRP) | United States | $0.091B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.066B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.056B | 19.33 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.051B | 0.00 |
| ImmuCell (ICCC) | United States | $0.043B | 0.00 |
| Senestech (SNES) | United States | $0.039B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.036B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.028B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.011B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.010B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.006B | 4.57 |
